Recent blog post.

• 

  European Pharma Group Proposes TEE Voucher System to Revitalize Antibiotics R&D

  Posted: 1 月 ago
• 

  KYBORA Advises Xbrane on Global Licensing Agreement with Intas

  Posted: 1 月 ago
• 

  Navigating Priority Review Voucher Eligibility: Beyond Rare Pediatric Disease Designation

  Posted: 1 月 ago
• 

  Understanding the Role of the Not Same Active Moiety Principle in RPDD and PRV Evaluations

  Posted: 2 月 ago
• 

  The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

  Posted: 5 月 ago